Business

Pharma Consolidation Rumors Stir Market

Updated 2026-08-06 09:55 UTC 2 sources Neutral

Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb have reignited debate over Big Pharma consolidation. Shares moved as investors grappled with potential implications.

Coverage timeline — 2 articles

MarketWatch

Investors are misreading this major economy — and creating a rare opportunity in government bonds

Buy 10-year Treasury gilts over U.S. Treasurys and other international bonds, advises TS Lombard.

2026-08-06 09:40 UTC

CNBC

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma consolidation.

2026-08-06 09:40 UTC